Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Net Cash Flow (2016 - 2025)

Palisade Bio has reported Net Cash Flow over the past 16 years, most recently at $128.2 million for Q4 2025.

  • Quarterly Net Cash Flow rose 7097.47% to $128.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $123.6 million through Dec 2025, up 4833.55% year-over-year, with the annual reading at $123.6 million for FY2025, 4833.55% up from the prior year.
  • Net Cash Flow was $128.2 million for Q4 2025 at Palisade Bio, up from -$190000.0 in the prior quarter.
  • Over five years, Net Cash Flow peaked at $128.2 million in Q4 2025 and troughed at -$3.9 million in Q1 2022.
  • The 5-year median for Net Cash Flow is -$1.1 million (2023), against an average of $7.2 million.
  • Year-over-year, Net Cash Flow crashed 3829.59% in 2022 and then soared 7097.47% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$98000.0 in 2021, then tumbled by 1534.69% to -$1.6 million in 2022, then tumbled by 79.78% to -$2.9 million in 2023, then skyrocketed by 161.84% to $1.8 million in 2024, then soared by 7097.47% to $128.2 million in 2025.
  • Per Business Quant, the three most recent readings for PALI's Net Cash Flow are $128.2 million (Q4 2025), -$190000.0 (Q3 2025), and -$1.8 million (Q2 2025).